Used in cancer research, particularly for its kinase inhibitory properties. Shows activity against Aurora A kinase and angiogenic kinases, making it a candidate for antitumor therapy. Investigated for use in treating solid tumors and hematological malignancies due to its ability to induce cell cycle arrest and apoptosis. Also studied for anti-angiogenic effects, which may help reduce tumor blood supply. Currently in preclinical and clinical development stages, not approved for routine therapeutic use.